Glenmark Secures U.S. FDA Approval to Expand RYALTRIS Nasal Spray Use for Children
Glenmark Specialty S.A. has received approval from the U.S. Food and Drug Administration (FDA) to expand the use of RYALTRIS […]
GLENMARK
Glenmark’s US Arm to Launch Sodium Phosphate Injection; Distribution to Begin in April
Glenmark Pharmaceuticals Ltd. has announced that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Sodium Phosphate Injection in […]
Glenmark Receives FDA Approval for Over-the-Counter Esomeprazole Magnesium Capsules for Heartburn Relief
Glenmark Specialty SA, a pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) to sell a […]
Glenmark and BeiGene Join Forces to Introduce Advanced Cancer Therapies in India
Glenmark Specialty S.A. (Glenmark), a subsidiary of the globally renowned Glenmark Pharmaceuticals Ltd., has entered into an exclusive marketing and […]
Glenmark Strengthens Nationwide Heart Health Initiative with New Phase of ‘India First Heart First’ Campaign
Glenmark Pharmaceuticals Ltd., a global leader in pharmaceuticals, has launched the next phase of their impactful ‘India First Heart First’ […]
Pharma major Glenmark recalls products from US market
Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market, as […]
Glenmark Pharma plans capital expense of $300 mn in three years
Pharma major Glenmark Pharmaceuticals has chalked out a $300 million capital expenditure plan for the next three years to fund […]
